Beta Bionics, Inc. (BBNX) Other Operating Expenses (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Other Operating Expenses data on file, last reported at $20.7 million in Q1 2026.

• Quarterly Other Operating Expenses rose 54.72% year-over-year to $20.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.7 million (up 60.51% YoY) and the FY2025 annual result came in at $61.4 million, up 65.57% from the prior year.
• Other Operating Expenses grew to $20.7 million in Q1 2026 per BBNX's latest filing, from $16.3 million in the prior quarter.
• The five-year high for Other Operating Expenses was $20.7 million in Q1 2026, with the low at $7.7 million in Q1 2024.
• Average Other Operating Expenses over 3 years is $13.2 million, with a median of $13.4 million recorded in 2025.
• The widest YoY moves for Other Operating Expenses: up 74.89% in 2025, down 51.18% in 2025.
• Beta Bionics' Other Operating Expenses stood at $10.8 million in 2024, then jumped by 51.18% to $16.3 million in 2025, then grew by 26.94% to $20.7 million in 2026.
• Business Quant data shows BBNX's Other Operating Expenses at $20.7 million in Q1 2026, $16.3 million in Q4 2025, and $16.0 million in Q3 2025.